A novel allosteric modulator of the cannabinoid CB1 receptor ameliorates hyperdopaminergia endophenotypes in rodent models
- Submitting institution
-
University of Aberdeen
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 174315711
- Type
- D - Journal article
- DOI
-
10.1038/s41386-020-00876-5
- Title of journal
- Neuropsychopharmacology
- Article number
- -
- First page
- 413
- Volume
- 46
- Issue
- 2
- ISSN
- 0893-133X
- Open access status
- Compliant
- Month of publication
- October
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
17
- Research group(s)
-
-
- Citation count
- 1
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The co-author statement on the publication does not provide a detailed description of the submitting author’s contribution. The submitting author made a substantial contribution to the conception and design of the study, to carrying out the study and helped draft the output. Confirmation by the corresponding author is available on request.
- Non-English
- No
- English abstract
- -
